Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_assertion type Assertion NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_head.
- NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_assertion description "[Thus CD44 may be a promising new epigenetic marker for diagnosis and a potential therapeutic target for the treatment of specific lymphoma subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_provenance.
- NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_assertion evidence source_evidence_literature NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_provenance.
- NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_assertion SIO_000772 20920234 NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_provenance.
- NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_assertion wasDerivedFrom befree-20140225 NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_provenance.
- NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_assertion wasGeneratedBy ECO_0000203 NP380077.RA63qKpEiijm5VPw9NucxcLK8XeTTJSSAevWtR0t-0wTA130_provenance.